Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1995-08-04
1999-10-19
Elliott, George C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
536 245, A61K 3170, C07H 2100
Patent
active
059689099
ABSTRACT:
The present invention provides a method of reducing the immunostimulatory effects of certain phosphorothioate oligonucleotides used to treat pathogen-mediated disease states and other medical conditions. Immunostimulatory effects of phosphorothioate oligonucleotides are reduced in accordance with the method of the invention by modifying at least one chemical structure within the phosphorothioate oligonucleotide to produce an immunostimulatory response-reducing phosphorothioate oligonucleotide, which is then administered to a mammal afflicted with the disease or condition being treated. The immune response of the mammal is also monitored in the method of the invention.
REFERENCES:
patent: 5663153 (1997-09-01), Hutcherson et al.
Concise Encyclopedia Chemistry, M. Eagleson trans. Walter de Gruyter, New York. p. 741, 1994.
Stein et al. Science 261: 1004-1012, Aug. 1993.
Mojcik et al. Clinical Immunol. Immunopath. 67: 130-136, May 1993.
Branda et al. Biochem. Pharmacol. 45: 2037-2043, Oct. 1993.
Goodchild. Bioconjugate Chem. 1(3): 165-187, 1990.
McIntrye et al. Antisense Res. Dev. 3:309-322, 1993.
Messina et al. Cell Immunol. 147: 148-157, 1993.
Kreig et al. Nature 374: 546-549, 1995.
Pisetsky et al. (1993) Life Sciences 54:101-107.
Kuramoto et al. (1992) Jpn. J. Cancer Res. 83:1128-1131.
Stein et al. (1993) Science 261:1004-1012.
Branda et al. (1993) Biochem. Pharm. 45:2037-2043.
Lisziewicz et al. (1994) Proc. Natl. Acad. Sci. USA 91:7942-7946.
Bayever et al. (1993) Antisense Res. Dev. 3:383-390.
Benbernou et al. (1993) Biochimie 75:55-61.
Yamamoto et al. (1992) J. Immunol. 148:4072-4076.
Mojcik et al. (1993) Clin. Immunol. and Immunopat. 67:130-136.
Tanaka et al. (1992) J. Exper. Medicine 175:597-607.
Horwitz et al. (1992) J. Virol. 66:2170-2179.
Zhao et al. (1986) Biochemical Pharmacology 51:173-182.
Pisetsky et al. (1993) Molecular Biology Reports 18:217-221.
Zhou et al. (1994) Nucleic Acids Research 22:453-456.
Agrawal Sudhir
Temsamani Jamal
Zhao Qiuyan
Elliott George C.
Hybridon, Inc.
Larson Thomas G.
LandOfFree
Method of modulating gene expression with reduced immunostimulat does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of modulating gene expression with reduced immunostimulat, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of modulating gene expression with reduced immunostimulat will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2055452